Logo do repositório
 
Publicação

Topical ocular delivery of nanoparticles with epoetin beta in Wistar Hannover rats

dc.contributor.authorSilva, Beatriz
dc.contributor.authorGonçalves, Lídia
dc.contributor.authorBraz, Berta São
dc.contributor.authorDelgado, Esmeralda
dc.date.accessioned2023-09-11T15:50:12Z
dc.date.available2023-09-11T15:50:12Z
dc.date.issued2023-01-27
dc.date.updated2023-02-27T14:09:38Z
dc.description.abstractTopical instillation of drugs targeting the posterior ocular segment is an expanding area of research. Chitosan and hyaluronic acid have remarkable mucoadhesive properties and potentially enhance pre-corneal retention time after topical instillation. Bearing this in mind, we explored the possibility of delivering epoetin beta (EPOβ) to the posterior segment of the eye in a chitosan-hyaluronic acid (CS/HA-EPOβ) nanoparticulate system using the topical route of administration. Complete ophthalmological examinations, electroretinography and microhematocrit evaluations were performed in Wistar Hannover (WH) rats, before and after topical administration of nanoparticles. The right eye received CS/HA-EPOβ and the left eye received only empty nanocarriers (control). Animals were split into 6 groups and at designated timepoints, all animals from each group (n = 3) were euthanized and both eyes enucleated. Retinal morphology and EPOβ ocular distribution were assessed, respectively, through hematoxylin and eosin (HE) and immunofluorescence staining. After topical administration, no adverse ocular signs were noted and no significant changes either in microhematocrits nor in electroretinographies were detected. During the study, intraocular pressure (IOP) was always kept within physiological range bilaterally. No histological changes were detected in any of the ocular globes. Immunofluorescence enabled the identification of EPOβ in the retina 12 h after the administration, its presence still being detectable at day 21. In conclusion, CS/HA nanoparticles could efficiently deliver EPOβ to the retina of WH rats after topical instillation, being considered biologically safe. Topical administration of this nanoformulation could be a valuable tool for retinal neuroprotection, decreasing risks associated with more invasive routes of administration, being cost effective and also increasing long-term patients’ compliance.pt_PT
dc.description.sponsorshipThis research was funded by the Fundação para a Ciência e a Tecnologia (FCT), Portugal (UID/DTP/04138/2019 and UIDB/04138/2020 to iMed.ULisboa, and is has also been funded by national funds through FCT-Fundação para a Ciência e a Tecnologia, I.P., under the Project UIDB/00276/2020 for CIISA and the Project LA/P/0059/2020 for AL4AnimalS); principal investigator grants CEECIND/03143/2017 (L. M. Gonçalves) and Beatriz Silva thanks to FCT for her fellowship SFRH/BD/130476/2017.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationSilva B, Gonçalves LM, São Braz B, Delgado E. Topical ocular delivery of nanoparticles with epoetin beta in Wistar Hannover rats. Sci Rep [Internet]. 27 de janeiro de 2023;13(1):1559. Disponível em: https://www.nature.com/articles/s41598-023-28845-0pt_PT
dc.identifier.doi10.1038/s41598-023-28845-0pt_PT
dc.identifier.issn2045-2322
dc.identifier.slugcv-prod-3147572
dc.identifier.urihttp://hdl.handle.net/10451/59204
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringer Naturept_PT
dc.relationLA/P/0059/2020pt_PT
dc.relationResearch Institute for Medicines
dc.relationResearch Institute for Medicines
dc.relationCentre for Interdisciplinary Research in Animal Health
dc.relationNot Available
dc.relationRetinal erythropoietin distribution and neuroprotective effect in a nanoparticulate drug delivery system after subconjunctival and topical adminstration in an animal glaucoma model
dc.relation.publisherversionhttps://www.nature.com/articles/s41598-023-28845-0pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.titleTopical ocular delivery of nanoparticles with epoetin beta in Wistar Hannover ratspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardNumberUID/DTP/04138/2019
oaire.awardNumberUIDB/04138/2020
oaire.awardNumberUIDB/00276/2020
oaire.awardNumberCEECIND/03143/2017/CP1476/CT0005
oaire.awardNumberSFRH/BD/130476/2017
oaire.awardTitleResearch Institute for Medicines
oaire.awardTitleResearch Institute for Medicines
oaire.awardTitleCentre for Interdisciplinary Research in Animal Health
oaire.awardTitleNot Available
oaire.awardTitleRetinal erythropoietin distribution and neuroprotective effect in a nanoparticulate drug delivery system after subconjunctival and topical adminstration in an animal glaucoma model
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FDTP%2F04138%2F2019/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04138%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00276%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/CEEC IND 2017/CEECIND%2F03143%2F2017%2FCP1476%2FCT0005/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F130476%2F2017/PT
oaire.citation.issue1pt_PT
oaire.citation.startPage1559pt_PT
oaire.citation.titleScientific Reportspt_PT
oaire.citation.volume13pt_PT
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStreamCEEC IND 2017
person.familyNameDiogo Gonçalves
person.familyNameSão Braz
person.familyNameDelgado
person.givenNameLídia Maria
person.givenNameBerta
person.givenNameEsmeralda
person.identifier294532
person.identifier.ciencia-id7211-22BA-86AD
person.identifier.ciencia-idB11B-C3C7-3ADF
person.identifier.ciencia-id8D1E-61D6-0F40
person.identifier.orcid0000-0002-6799-2740
person.identifier.orcid0000-0003-2688-0459
person.identifier.orcid0000-0001-9383-1310
person.identifier.scopus-author-id56008623000
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.cv.cienciaid7211-22BA-86AD | Lídia Maria Diogo Gonçalves
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication3265148d-dc2d-4601-a832-2e72f7be5662
relation.isAuthorOfPublication246b38de-6a75-4ff0-88fe-ec4b57856728
relation.isAuthorOfPublication43f9876f-839a-4f6a-be34-941488630b8b
relation.isAuthorOfPublication.latestForDiscovery246b38de-6a75-4ff0-88fe-ec4b57856728
relation.isProjectOfPublicationf7ed2a0a-c67e-4c12-ad63-b550724e24bf
relation.isProjectOfPublicationbb00962c-ed82-4d7a-bc37-61df49767d93
relation.isProjectOfPublication8563a044-0c86-49a8-a275-8b1bb62cc0d8
relation.isProjectOfPublication1b37be44-5343-44b3-a5b0-3805bd6ad22b
relation.isProjectOfPublication0d64307f-85ff-4c0c-ab28-d0de1eedb6c3
relation.isProjectOfPublication.latestForDiscoverybb00962c-ed82-4d7a-bc37-61df49767d93

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
BSilva_et_al_2023b.pdf
Tamanho:
2.07 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: